via OTC PR WIRE — North American Cannabis Holdings, Inc.(USOTC:USMJ) (“USMJ”) today issued an update on its plans with West Coast Venture Group, Corp. (OTCQB:WCVC) (“WCVC”).
WCVC $3 Million In Annual Revenue With $0.07 PPS and $0.20 PPS Potential
WCVC is the owner and operator of Illegal Burger operating in cannabis friendly Colorado and introducing their very own cannabis infused menu. WCVC is a fully reporting company with audited financials reporting over $3 million in annual revenue. Based on a recent analysis published by WCVC, on conventional market comparable valuations, WCVC can support a $0.20 PPS.
USMJ has piloted a concept restaurant called The AmeriCanna Cafe. In a strategy to expand the pilot, USMJ spun the AmeriCanna Cafe off into an independently listed company, Priority Aviation, Inc. (USOTC:PJET). In accordance with the spinoff deal, PJET is undergoing a name change in conjunction with its new business direction. Simultaneously, with the spinoff, USMJ entered into a partnership with WCVC to advance the AmeriCanna Cafe restaurant initiative. Based on WCVC’s momentum stemming from WCVC’s management expertise in the restaurant industry, USMJ and PJET management plan to give WCVC increased authority on the overall AmeriCanna Cafe initiative. USMJ will provide logistics services and PJET will work primarily as an investor on the AmeriCanna Cafe initiative.
To learn more visit www.USMJ.com and www.GrowUSMJ.com.
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
CEO North American Cannabis Holdings, Inc.